Kathryn Fitzgerald

Assistant Professor

Johns Hopkins University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kathryn Fitzgerald is an Assistant Professor at Johns Hopkins University in the United States. Her research primarily focuses on multiple sclerosis, exploring areas such as disease activity, the impact of comorbidities, and the psychosocial aspects of the condition. Recent publications delve into the detection of relapses, biological aging reversal through diet, and the differences in onset presentation among diverse populations. Additional interests include the implications of MRI findings and quality of life in patients with multiple sclerosis.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Sarah Levy

Assistant Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

Kathryn Fitzgerald

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis

Comorbidities, safety and persistence in phase III clinical trials in multiple sclerosis

Frequency and potential risk factors associated with the development of asymptomatic T2 hyperintense cervical spine lesions on MRI in patients with relapsing-remitting multiple sclerosis

Increased contact with clinical trial participants may improve confirmed multiple sclerosis relapse detection

Fasting Mimicking Diets Reverse Accelerated Biological Aging in Multiple Sclerosis

The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White Americans

Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores

Evidence of symptom specificity for depression in multiple sclerosis: A two sample Mendelian randomization study

Author Response: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations

Quality of life is impaired in myelin oligodendrocyte glycoprotein antibody associated disease

Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic Approaches

Polygenicity of Comorbid Depression in Multiple Sclerosis

Deep gray matter substructure volumes and depressive symptoms in a large multiple sclerosis cohort

Mediterranean diet is linked to less objective disability in multiple sclerosis

Associations of sNfL with clinico‐radiological measures in a large MS population

Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: a retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)

Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease

Mitochondrial measures in neuronally enriched extracellular vesicles predict brain and retinal atrophy in multiple sclerosis

Association of Multiple Sclerosis Prevalence With Sociodemographic, Health Systems, and Lifestyle Factors on a National and Regional Level

Contributors to Serum NfL Levels in People without Neurologic Disease

Collaborators (16)

Sarah Levy

Peter A. Calabresi

Elias S Sotirchos

Lesley Graff

jasvinder singh

Yujie Wang

Amber Salter

Ellen Mowry

Farren Briggs

Ruth Ann Marrie

Carlos A Pardo

Sarah Simmons

Shiv Saidha

Kaarina Kowalec

Ali Manouchehrinia

Pablo Villoslada

Make your next move.